Radio Havana Cuba | Heberferon, another flagship product of Cuban biotechnology

Heberferon, another flagship product of the Center for Genetic Engineering and Biotechnology, is consolidated in primary and secondary care Health should already be used in 50 institutions in Cuba.

Iraldo Bello, head of the drug research project, pointed out that it is based on a combination of alpha and gamma interferons for the effective treatment of basal cell carcinomas. , the most common skin tumor and high incidence in the world.

The specialist noted that the drug has been applied in hospitals, which allowed mitido treat non-melanoma skin cancer, closely related to the incidence of sunlight and aging.

Bello pointed out that this therapy is not for all tumors of this type, but its use is recommended in basal cell carcinomas They are found in areas such as the nose, the ear, the eyelids and the periocular area. (Source: RReloj)